Back to search results

ACT vs CQ With Tafenoquine for P. Vivax Mono-infection

Abroad (travel likely)RecruitingPHASE4

Conditions

Malaria · Malaria, Vivax · Plasmodium Vivax Malaria

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Shoklo Malaria Research Unit (SMRU), Mae Sot, Changwat Tak, Thailand

    Contact: Study coordinator (Aung Pyae Phyo, DPhil) · aungpyaephyo@tropmedres.ac
    Contact: Principal Investigator (Francois Nosten, MD)
    Aung Pyae Phyo, MD (Sub-investigator)
    Nicholas J White, FRS (Sub-investigator)
    James Watson, PhD (Sub-investigator)
    Mallika Imwong, PhD (Sub-investigator)
    Germana Bancone, PhD (Sub-investigator)
    Joel Tarning, PhD (Sub-investigator)
    Cindy S Chu, PhD (Sub-investigator)
    Aung Myint Thu, MSc (Sub-investigator)
    Khin Mg Lwin, MD (Sub-investigator)
Study leads

  • Francois Nosten, Prof

    Principal Investigator

    Shoklo Malaria Research Unit

View source on ClinicalTrials.gov(opens in a new tab)